Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Abernethy
Safety and Acceptability of Clozapine and Risperidone in Progressive Multiple Sclerosis: A Phase 1, Randomized, Blinded, Placebo-Controlled Trial
Related publications
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
New England Journal of Medicine
Medicine
A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)
PLoS ONE
Multidisciplinary
A Phase 1 Randomized Placebo-Controlled Safety and Pharmacokinetic Trial of a Tenofovir Disoproxil Fumarate Vaginal Ring
AIDS
Infectious Diseases
Allergy
Immunology
Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial
Archives of Neurology
Nephroprotection by Theophylline in Patients With Cisplatin Chemotherapy: A Randomized, Single-Blinded, Placebo-Controlled Trial
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
Gastroenterology
Hepatology
Gastroenterology
Adalimumab for Nail Psoriasis: Efficacy and Safety Over 52 Weeks From a Phase‐3, Randomized, Placebo‐Controlled Trial
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Alcoholism: Clinical and Experimental Research
Medicine
Psychiatry
Mental Health
Toxicology
